CVS Health Corporation
0 DAYS LEFT TO SEEK LEAD PLAINTIFF STATUS
Case Summary | |
Company Name: | CVS Health Corporation |
Stock Symbol : | NYSE: CVS |
Class Period Start: | 05/21/2015 |
Class Period End: | 02/20/2019 |
Lead Plaintiff motion: | 04/26/2019 |
Date Filed: | 02/25/2019 |
Type of Case: | Securities Class Action |
Court: | U.S. District Court for the Southern District of New York |
Summary: | Thieler Law Corp advises investors with losses exceeding $100,000 of the April 26, 2019 lead plaintiff deadline in a class action lawsuit filed against CVS Health Corporation (NYSE: CVS) (“CVS” or “the Company”). The suit is pending in the U.S. District Court for the Southern District of New York and investors, who purchased CVS Health Corporation securities between May 21, 2015 and February 20, 2019, have until April 26, 2019 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class. If you purchased CVS Health Corporation securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 377 - 4324 or emailing mail@thielerlaw.com . No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class. The complaint alleges that during the Class Period defendants made false and misleading statements and/or allegedly failed to disclose that CVS’s financial condition and expected earnings were deteriorating as a result of rising costs and poor results associated with its acquisition of Omnicare, Inc.; and as a result, CVS’s public statements were materially false and misleading at all relevant times. On February 20, 2019, CVS revealed the Company's fourth quarter and full year financial and operating results and provided 2019 full year guidance. CVS advised investors that adjusted earnings in 2019 would be $6.68 to $6.88 per share, compared with the $7.36 average of market estimates, citing rising costs and poor results related to the Company's 2015 acquisition of Omnicare. If you were negatively impacted by your investment in CVS Health Corporation securities between May 21, 2015 and February 20, 2019 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation. Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm. Materials are provided for informational purposes only and do not constitute legal advice. We are only licensed to practice law in Germany. We are neither licensed nor qualified to render advice on US Federal or State law. Thieler Law Corp 2534 State Street - Suite 406, San Diego, CA 92101 by email: mail@thielerlaw.com or telephone at +1 (619) 377 - 4324 or visit our website http://www.thielerlaw.com/ or Facsimile: +1 (619) 785 – 3185 |